Nanomi Receives CMO Award for Life Science Leadership in Drug Delivery

Dr. Shahin Fesharaki, Global Chief Scientific Officer, Lupin, said, "This recognition underscores our dedication to advancing science and highlights Nanomi's pioneering efforts in drug delivery. We remain committed to innovation that enables the delivery of high-quality medicines that significantly improve patient outcomes."

Established in 2011, the CMO Leadership Awards are presented by Outsourced Pharma and Life Science Connect with research by Orientation Marketing and recognize top outsourcing partners, based on the feedback from sponsor companies who outsource manufacturing. This year is the first year that the CMO Leadership Award is juried.

About Lupin

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women's health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries - Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

To know more, visit www.lupin.com or follow us on LinkedIn  https://www.linkedin.com/company/lupin. 

To know more about Nanomi, visit www.nanomi.com or follow on LinkedIn https://www.linkedin.com/company/nanomi.

View original content:https://www.prnewswire.co.uk/news-releases/nanomi-receives-cmo-award-for-life-science-leadership-in-drug-delivery-302407914.html